Eton Pharmaceuticals (ETON) Free Cash Flow (2018 - 2025)

Eton Pharmaceuticals (ETON) has 8 years of Free Cash Flow data on file, last reported at -$11.6 million in Q4 2025.

• For the quarter ending Q4 2025, Free Cash Flow fell 1392.92% year-over-year to -$11.6 million; the trailing twelve-month figure through Dec 2025 stood at $10.2 million (up 980.7% YoY), and the FY2025 full-year result was $10.2 million, up 980.7% from the prior year.
• Free Cash Flow retreated to -$11.6 million in Q4 2025, from $11.7 million in the prior quarter.
• In the past five years, Free Cash Flow ranged from a high of $11.7 million in Q3 2025 to a low of -$11.6 million in Q4 2025.
• A 5-year average of $900250.0 and a median of $1.0 million in 2022 frame the typical range for Free Cash Flow.
• Across the five-year window, Free Cash Flow surged 763.96% in 2022 and tumbled 1392.92% in 2025, its largest moves.
• Tracing ETON's Free Cash Flow over 5 years: stood at -$5.1 million in 2021, then soared by 155.22% to $2.8 million in 2022, then sank by 86.32% to $387000.0 in 2023, then slumped by 300.78% to -$777000.0 in 2024, then plunged by 1392.92% to -$11.6 million in 2025.
• Business Quant data shows ETON's Free Cash Flow at -$11.6 million in Q4 2025, $11.7 million in Q3 2025, and $8.0 million in Q2 2025.